
Tart cherries were found to reduce the risk of stroke, finds new study.
A class of drugs called PPAR agonists that help regulate fat and glucose was considered promising by doctors who prescribed them for patients with metabolic syndrome - a collection of risk factors linked to heart disease and type 2.
Advertisement
However, studies have shown the long-term use of these drugs can also increase stroke risk, which has prevented many from securing FDA approval.
The new research from the U-M Cardioprotection Research Laboratory suggests that tart cherries can reduce the risk of stroke even when taken with these pharmaceutical options.
The group's previous research has shown that intake of US produced, Montmorency tartcherries activates PPAR isoforms (peroxisome proliferator activating receptors) in many of the body's tissues.
Researchers believe that anthocyanins - the pigments that give the fruit its red color - may be responsible for PPAR activation.
PPARs regulate genes involved in fat and glucose metabolism, and when modified can help reduce the risk of cardiovascular disease.
PPAR agonists, among them medications such as Actos (pioglitazone), act in a similar way but cardiovascular side effects have limited their use.
The researchers compared the effect of tart cherries and the drug Actos in stroke-prone rats by measuring the animals' systolic blood pressure as well as locomotion, balance, coordination, all of which can show the aftereffects of a stroke.
By putting the rats through various physical tests, such as walking on a tapered beam and climbing a ladder, the researchers found that compared to Actos, tart cherry intake significantly improved balance and coordination, and at the same time lowered blood pressure.
While the research results indicate that rats who consumed only tart cherries had the best results, those who had the combination of tart cherries and Actos also did better than those who only took the drug.
Source: ANI
Advertisement
The group's previous research has shown that intake of US produced, Montmorency tartcherries activates PPAR isoforms (peroxisome proliferator activating receptors) in many of the body's tissues.
Researchers believe that anthocyanins - the pigments that give the fruit its red color - may be responsible for PPAR activation.
PPARs regulate genes involved in fat and glucose metabolism, and when modified can help reduce the risk of cardiovascular disease.
PPAR agonists, among them medications such as Actos (pioglitazone), act in a similar way but cardiovascular side effects have limited their use.
The researchers compared the effect of tart cherries and the drug Actos in stroke-prone rats by measuring the animals' systolic blood pressure as well as locomotion, balance, coordination, all of which can show the aftereffects of a stroke.
By putting the rats through various physical tests, such as walking on a tapered beam and climbing a ladder, the researchers found that compared to Actos, tart cherry intake significantly improved balance and coordination, and at the same time lowered blood pressure.
While the research results indicate that rats who consumed only tart cherries had the best results, those who had the combination of tart cherries and Actos also did better than those who only took the drug.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings

Latest Diet & Nutrition News

The nutritional profile of American diet can be significantly improved by substituting small amounts of pulses for refined grains and common protein sources.

Lowering the intake of isoleucine in diet can extend lifespan, promote a slim body, anti-aging properties, and reduce cancer and prostate health issues.

Keep Thanksgiving leftovers safe: Refrigerate promptly, use airtight containers, label and date, and reheat properly.

Poor nutrition raises the risk of type 2 diabetes, and mental issues like anxiety and depression. Nutrition interventions aid in managing these health issues.

Micronutrient deficiencies may play a crucial role in the worldwide surge of antibiotic resistance.